GH1 and Creutzfeldt Jacob disease: The Medical Research Council (MRC) Prion Unit/National Prion Clinic enrolled two patients with iatrogenic growth hormone related CJD into a clinical trial of quinacrine (PRION-1) (Collinge et al., 2009) between 2002 and 2006 and four others were seen by the Unit over that period.